These insights underlie PureTech’s approach to designing novel categories of therapeutics to address debilitating and devastating CNS disorders, and the related IP has been exclusively licensed to PureTech Health from the University of Virginia Licen...
TypeZero Technologies received the first investment from the UVA LVG Seed Fund in 2016 CHARLOTTESVILLE, Va. (September 11, 2018) – The University of Virginia Licensing & Ventures Group (UVA LVG) Seed Fund has exited from TypeZero Technologies, In...
The water-disinfecting device is a ceramic tablet known as the MadiDrop, created in the lab of Dr. James A. Smith of the School of Engineering and Applied Science and produced by a nonprofit founded with support from UVA’s Licensing and Ventures Grou...
Bill Stilley is CEO of Charlottesville-based Adial Pharmaceuticals, which is developing a genetically targeted drug to treat alcoholism in patients with a particular genetic profile. The company went public July 27, in the first initial public offeri...
PsiKick Steam Trap Monitor Enables Real-Time Alerts for Quick Intervention to Avoid Costs of Wasted Energy and Downtime; PsiKick’s Complete System Spans Sensing Hardware to Cloud Analytics...
According to the American Epilepsy Society, one in 26 Americans will develop epilepsy in their lifetime. The fourth most common neurological disease, epilepsy predisposes a person to recurrent unprovoked seizures and is a major public health concern ...
Now, scientists at the University of Virginia School of Medicine in Charlottesville have developed an approach that looks set to overcome this barrier. They describe their "single-agent dual-specificity targeting" method for ovarian cancer in a study...
"Ultimately," he said, "a clinical trial in ovarian cancer patients is my big goal, and, with the help of the UVA Licensing & Ventures Group, we are looking for industrial partners, too."...
Dexcom, TypeZero and the University of Virginia have had a longstanding, productive relationship in developing important technologies for diabetes management, including inControl for integration with both automated insulin delivery (“AID”) and smart ...
For decades, scientists have believed that the nervous system and the immune system operated independent of one another – the former running the body and the second protecting it. University of Virginia neuroscientist Jonathan Kipnis joins guest host...